P.D. : *.- Yondelis is approved for marketing in Canada for ovarian Cancer with what the Unidenses State always presumed would be pioneers in oncology... will have that travel to Mexico or Canada be able to access the Yondelis be just the FDA to stop wasting time since there are patients who do not have
QUEDAN ENTRE 2 Y 8 JORNADAS BURSÁTILES PARA SABER SI LA USFDA APRUEBA IMFORTE ( LURBINECTEDIN / ATEZOLIZUMAB BY JAZZPHARMA ) PHARMAMAR Y ROCHE ) EN ESTADOS UNIDOS PARA EL TRATAMIENTO DE MANTENIMIENTO EN PRIMERA LINEA EN CÁNCER DE PULMÓN MICROCÍTICO ... Y YA PARECE COMPLICADO QUE ALGUIEN QUIERA VENDER SUS ACCIONES ... LÓGICAMENTE NINGUNA DE LAS TRES FARMACÉUTICAS IMPLICADAS EN EL PRECISO PUEDEN DECIR NADA AL RESPECTO HASTA QUE LA USFDA SE PRONUNCIE ...
20 mayo 2010
US is with the ass in the air in oncology. Yondelis only Mexico ( STS ) and Canada for Treatment Ovarian Cancer .
P.D. : *.- Yondelis is approved for marketing in Canada for ovarian Cancer with what the Unidenses State always presumed would be pioneers in oncology... will have that travel to Mexico or Canada be able to access the Yondelis be just the FDA to stop wasting time since there are patients who do not have